Empagliflozin in Post-Transplantation Diabetes Mellitus
NCT03113110
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Posttransplant Diabetes Mellitus
Interventions
DRUG:
Empagliflozin 10 mg
Sponsor
Medical University of Vienna